PDE4A and ovarian cancer: In 2010, another investigation showed that this isoflavonoid as a tyrosine kinase inhibitor activates autophagy in ovarian cancer cells through the PDE4A/PDE4A4 (phosphodiesterase 4A) and SQSTM1 pathways.